Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin

To address the poor prognosis of mixed lineage leukemia (MLL)-rearranged infant acute lymphoblastic leukemia (iALL), we generated a panel of cell lines from primary patient samples and investigated cytotoxic responses to contemporary and novel Food and Drug Administration-approved chemotherapeutics....

Full description

Bibliographic Details
Main Authors: Cruickshank, M., Ford, J., Cheung, Laurence, Heng, J., Singh, S., Wells, J., Failes, T., Arndt, G., Smithers, N., Prinjha, R., Anderson, D., Carter, K., Gout, A., Lassmann, T., O'Reilly, J., Cole, C., Kotecha, R., Kees, U.
Format: Journal Article
Published: 2017
Online Access:http://hdl.handle.net/20.500.11937/59582